Metropolitan Life Insurance Company (MetLife)’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-108	Closed	-$53.9K	–	2862
2021 Q3	$53.9K	Sell	108 -94	-47%	-$43.6K	﹤0.01%	2751
2021 Q2	$101K	Buy	+202	New	+$108K	﹤0.01%	2588
2015 Q2	–	Sell	-118	Closed	-$267K	–	2715
2015 Q1	$267K	Buy	+118	New	+$201K	﹤0.01%	1898
2014 Q3	–	Sell	-155	Closed	-$388K	–	2747
2014 Q2	$388K	Buy	155 +73	+89%	+$149K	﹤0.01%	2022
2014 Q1	$157K	Hold	82	–	–	﹤0.01%	2594
2013 Q4	$176K	Hold	82	–	–	﹤0.01%	2558
2013 Q3	$185K	Sell	82 -1	-1%	-$1.93K	﹤0.01%	2482
2013 Q2	$143K	Buy	+83	New	+$132K	﹤0.01%	2583

Other funds holding AMPE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AMPE Position: Q4 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2021, closing a stake of 108 shares — an estimated $53.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AMPE in Q2 2013 and held it in 8 quarters. The position peaked at $388K in Q2 2014. 131 funds tracked by Wall St. Rank hold AMPE as of Q4 2021.

Metropolitan Life Insurance Company (MetLife) reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2021 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 108 Ampio Pharmaceuticals Inc. shares in Q4 2021, an estimated $53.9K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 8 quarters.
Metropolitan Life Insurance Company (MetLife)'s Ampio Pharmaceuticals Inc. position peaked at $388K in Q2 2014.
131 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.